Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Podrobná bibliografie
Hlavní autoři: Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Médium: Conference item
Vydáno: 2009